hahaha, email management : ) Looks like the free fall has subsided for now, is 4 the bottom? Tomorrow will be interesting as I think someone has been dumping last two Thursdays for their own reasons.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%